The Food and Drug Administration (FDA) has sent a warning letter to reality TV star Savannah Chrisley, 28, concerning misleading statements on her prescription weight loss website, GoodGirlRX. The agency flagged phrases such as ‘FDA-approved meds,’ ‘FDA-approved options,’ and ‘clinically proven GLP-1 results’ as inaccurate for compounded semaglutide and tirzepatide products.
Details of the FDA Warning
Compounded drugs offered on the site undergo no FDA evaluation for safety or effectiveness, violating federal law. The letter required corrections within 15 business days to avoid potential legal action. Officials emphasized that such claims falsely suggest regulatory approval.
Website Adjustments for Compliance
GoodGirlRX now displays disclaimers clarifying that its GLP-1 medications lack FDA approval. The term ‘clinically proven results’ has shifted to ‘clinically studied results,’ addressing the FDA’s concerns.
Chrisley’s Response
Chrisley stated, “This was about website wording, not patient safety. There were no fines and no disciplinary action. We’re proud to help women access licensed physicians and we welcome the FDA’s guidance.” The platform launched in March 2025 and connects users to weight loss treatments, including compounded versions of semaglutide (found in Ozempic and Wegovy) and tirzepatide (found in Mounjaro and Zepbound).
Chrisley’s Weight Loss Journey
Last November, Chrisley shared her goal to lose 25 pounds on her Unlocked podcast, aiming to drop from nearly 160 pounds to around 135 pounds at 5-foot-7. She discussed past struggles with weight fluctuations and inconsistent use of injections due to appetite suppression.
“My weight has always fluctuated. Always. Like right now, I am almost 160 pounds. Probably more than that,” she revealed to her mother, Julie Chrisley, 53. Committed this time, Chrisley chose tirzepatide for fewer side effects compared to options like Ozempic.
“I love tirzepatide, which is great… So then I can compare my bloodwork before taking it and after taking it and see where my biological age is, how my A1C is, all those things,” she explained. She and Julie plan to lose weight together, with Julie targeting 20 pounds.
Chrisley emphasized wanting to feel good in her body: “I want to be skinny… But I want to be pretty thin because now when I put on some of my jeans, I don’t like it when I go to put on a pair of jeans and they don’t fit.”
Tirzepatide Overview
Tirzepatide requires weekly injections on the same day. The Mayo Clinic notes it primarily treats type 2 diabetes but also aids weight loss and maintenance in patients with obesity linked to specific conditions.
